Skip to main content

Family sells bracelets to benefit Chediak-Higashi Syndrome

Last year we had the first-ever Chediak-Higashi Syndrome family conference. One of the families that came was Riley's family from Canada. Riley charmed everyone. You'd never guess watching him run around with so much energy just how much he'd already been through in his short life.

Riley's family is making bracelets out of pop tops to try to raise money. This article appeared in the local paper. How awesome!!!! And, the photo is great!!!!

Here's the article:

Handmade bracelets help Riley



Buying a bracelet in Fort Langley will help in the efforts to find a cure for an extremely rare blood disorder, that affects a young boy in Walnut Grove


By Troy Landreville, Langley AdvanceOctober 27, 2011






Riley Tenhoeve, five, and his mom Selena sported bracelets being sold to raise money to find a cure for Chediak-Higashi Syndrome, a rare blood disorder that Riley was born with.


Photograph by: Troy Landreville, Langley AdvanceFive-year-old Riley Tenhoeve is a pretty typical kindergartner.






The jovial Walnut Grove tyke is a ball of frenetic energy who never stops moving, keeping his parents Lance and Selena simultaneously entertained and busy.






His passion for dirt biking and quadding is so strong, most mornings he pulls the pillowcase off his pillow and plays what he calls, "pillow dirt bikes."






"He's crazy energetic," Selena said. "He never stops. He doesn't slow down unless he's asleep. He's very friendly and chatty. He charms everybody, everywhere he goes."






The happy-go-lucky tyke also happens to have an extremely rare blood disorder called Chediak-Higashi Syndrome.

To read the full article, go to: http://www.langleyadvance.com/Handmade+bracelets+help+Riley/5613466/story.html






Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria